share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

DA Davidson對Usana Health Sciences保持中立,將目標價提高至56美元
Benzinga ·  2023/04/26 10:12

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $52.5 to $56.

DA Davidson分析師琳達·博爾頓·韋瑟維持Usana Health Sciences(紐約證券交易所代碼:USNA)的中性,並將目標股價從52.5美元上調至56美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論